agilon health inc. Quarterly Cash Flow Statement
NYSE: AGLHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
agilon health inc. free cash flow
In the quarter ended Jun 30, 2026, agilon health inc. generated -$57.3 million of operating cash flow and spent $3.4 million on capital expenditures. That left free cash flow of -$60.7 million, a free-cash-flow margin of -4.1% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
agilon health inc. cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 17.96M | 48.92M | -188.88M | -110.21M | -104.37M | 12.11M | -105.79M | -117.61M | -30.66M | -6.03M | -230.48M | -31.48M |
| Net Income growth (YoY) | — | +303.86% | — | — | — | — | — | — | — | -137.81% | — | — |
| Depreciation & Amortization | 6.86M | 6.79M | 6.97M | 7.43M | 7.32M | 6.88M | 6.49M | 6.22M | 5.91M | 5.84M | 5.15M | 5.31M |
| Stock-Based Compensation | 23.83M | 6.25M | 9.52M | 7.50M | 15.38M | 16.72M | 2.28M | 13.26M | 18.21M | 16.91M | 15.52M | 20.74M |
| Change in Working Capital | -113.99M | -8.43M | — | 92.72M | 52.88M | -38.79M | — | 92.14M | -3.98M | -63.34M | — | 6.27M |
| Operating Cash Flow | -57.30M | 23.73M | -20.54M | -18.15M | -35.09M | -31.99M | 16.42M | -7.70M | -18.72M | -47.78M | -61.17M | -13.02M |
| Capital Expenditures | -3.45M | -3.10M | -2.97M | -3.17M | -3.25M | -3.85M | -3.27M | -3.53M | -3.31M | -3.14M | -3.93M | -4.09M |
| Investing Cash Flow | 19.91M | 19.27M | 22.58M | 18.66M | 70.46M | -23.09M | 23.67M | 46.56M | 18.22M | 51.44M | -2.20M | -11.03M |
| Share Repurchases | — | — | — | — | — | — | — | 0 | — | — | 0 | 0 |
| Debt Repaid | 0 | -3.50M | 0 | 0 | 0 | 0 | 0 | -1.25M | -1.25M | -1.25M | -1.25M | -1.25M |
| Financing Cash Flow | 4.63M | -5.15M | -17.00K | -236.00K | -2.58M | -161.00K | -22.00K | -1.41M | -1.71M | 559.00K | -845.00K | 1.41M |
| Net Change in Cash | -32.76M | 37.85M | 2.03M | 268.00K | 32.79M | -55.24M | 40.07M | 37.45M | -2.21M | 4.22M | -64.21M | -22.64M |
| Free Cash Flow | -60.74M | 20.63M | -23.50M | -21.33M | -38.34M | -35.84M | 13.15M | -11.24M | -22.03M | -50.91M | -65.10M | -17.11M |
This table shows 12 quarterly periods of agilon health inc.'s cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow AGL's reporting calendar. What is a cash flow statement?